The head of the National Institutes of Health told Congress on Wednesday that U.S. health officials will not skip or abbreviate any safety assessments in the development of a coronavirus vaccine.
The head of the National Institutes of Health told Congress on Wednesday that U.S. health officials will not skip or abbreviate any safety assessments in the development of a coronavirus vaccine.